![Cabozantinib N-oxide Impurity; 4-(4-(1-((4-fluorophenyl)carbamoyl)cyclopropane-1-carboxamido)phenoxy)-6,7-dimethoxyquinoline 1-oxide; N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N’-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (CAS: 1621681-63-7)](https://drjcrbio.com/wp-content/uploads/JCCZT-05-150x72.png)
Cabozantinib N-oxide Impurity; 4-(4-(1-((4-fluorophenyl)carbamoyl)cyclopropane-1-carboxamido)phenoxy)-6,7-dimethoxyquinoline 1-oxide; N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N’-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (CAS: 1621681-63-7)
Cabozantinib, Cabozantinib N-oxide Impurity
Description
| Code: JCCZT-05 |
| CAS: 1621681-63-7 |
| Chemical Formula: C28H24FN3O6 |
| Molecular Weight: 517.51 |
| Category: Reference Standards/API Drug Metabolites/EP Impurities/USP Impurities |
| Status: Limited Stock ; Contact: sales@drjcrbio.com |
| Application: Manufacturer of Cabozantinib N-oxide Impurity; 4-(4-(1-((4-fluorophenyl)carbamoyl)cyclopropane-1-carboxamido)phenoxy)-6,7-dimethoxyquinoline 1-oxide; N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N’-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (CAS: 1621681-63-7) is useful as reference Impurity standard. |
